Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Bernstein Downgrades Lam Research to Market Perform

Bernstein analyst Stacy Rasgon downgrades Lam Research (NASDAQ:LRCX) from Outperform to Market Perform.
byBenzinga Newsdesk
March 13, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Bernstein analyst Stacy Rasgon downgrades Lam Research (NASDAQ:LRCX) from Outperform to Market Perform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Reported Late Tuesday, MediciNova Announces Additional Results Regarding The Effects Of MN-001 On Serum Lipid Panel In Type 2 Diabetes And NAFLD Patients Presented At IDF 2022 Congress, The Annual Meeting Of The International Diabetes Federation

By Benzinga Newsdesk
December 7, 2:11 AM
ediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova's Chief Medical

MNOV